[HTML] mdpi.com

[HTML][HTML] Harnessing immune response in acute myeloid leukemia

C Riva, C Vernarecci, P Minetto, R Goda… - Journal of Clinical …, 2023 - mdpi.com
Despite the results achieved with the evolution of conventional chemotherapy and the
inclusion of targeted therapies in the treatment of acute myeloid leukemia (AML), survival is …
被引用次数：5 相关文章
[HTML] nih.gov

[HTML][HTML] Harnessing Immune Response in Acute Myeloid Leukemia

C Riva, C Vernarecci, P Minetto, R Goda… - Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
Despite the results achieved with the evolution of conventional chemotherapy and the
inclusion of targeted therapies in the treatment of acute myeloid leukemia (AML), survival is …

Harnessing Immune Response in Acute Myeloid Leukemia

C Riva, C Vernarecci, P Minetto, R Goda… - Journal of Clinical …, 2023 - europepmc.org
Despite the results achieved with the evolution of conventional chemotherapy and the
inclusion of targeted therapies in the treatment of acute myeloid leukemia (AML), survival is …

Harnessing Immune Response in Acute Myeloid Leukemia

C Riva, C Vernarecci, P Minetto… - Journal of clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
Despite the results achieved with the evolution of conventional chemotherapy and the
inclusion of targeted therapies in the treatment of acute myeloid leukemia (AML), survival is …

Harnessing Immune Response in Acute Myeloid Leukemia.

C Riva, C Vernarecci, P Minetto… - Journal of Clinical …, 2023 - search.ebscohost.com
Despite the results achieved with the evolution of conventional chemotherapy and the
inclusion of targeted therapies in the treatment of acute myeloid leukemia (AML), survival is …

Harnessing Immune Response in Acute Myeloid Leukemia

C Riva, C Vernarecci, P Minetto… - Journal of Clinical …, 2023 - search.proquest.com
Despite the results achieved with the evolution of conventional chemotherapy and the
inclusion of targeted therapies in the treatment of acute myeloid leukemia (AML), survival is …

Harnessing Immune Response in Acute Myeloid Leukemia.

C Riva, C Vernarecci, P Minetto, R Goda… - Journal of Clinical …, 2023 - europepmc.org
Despite the results achieved with the evolution of conventional chemotherapy and the
inclusion of targeted therapies in the treatment of acute myeloid leukemia (AML), survival is …